510(k) K901156
K901156 is an FDA 510(k) premarket notification submitted by Granbio, Inc. for the device "EIA FOR IGG ANTIBODY TO EBV VCA IN HUMAN SERUM". The FDA issued a decision of Substantially Equivalent on September 12, 1990. The device falls under product code GNP (Antiserum, Cf, Epstein-Barr Virus), a Class I device regulated under 21 CFR 866.3235. Granbio, Inc. has at least 7 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- September 12, 1990
- Date Received
- March 13, 1990
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Antiserum, Cf, Epstein-Barr Virus
- Device Class
- Class I
- Regulation Number
- 866.3235
- Review Panel
- MI
- Submission Type